Table 3. Dosing intervals by dose number and timing status.
Doublet | Triplet | Quadruplet | |
N = 818 | N = 1464 | N = 60 | |
On-Time† | 745 (91%) | 1005 (69%) | 21 (35%) |
Early Dosing | |||
Dose 2 from Dose 1 | 0 (0%) | 2 (<1%) | 2 (3%) |
Dose 3 from Dose 2 | 27 (2%) | 2 (3%) | |
Dose 3 from Dose 1‡ | 56 (4%) | 4 (7%) | |
Late Dosing | |||
Dose 2 from Dose 1 | 73 (9%) | 46 (3%) | 1 (2%) |
Dose 3 from Dose 1 | 83 (6%) | 3 (5%) | |
Two Dosing Intervals Inappropriately Timed | 20 (1%) | 2 (3%) | |
Extra doses after a mistimed three dose series | 32 (53%) | ||
Extra doses after an appropriately timed three dose series* | 7 (12%) |
†Significant difference among doublet, triplet and quadruplet on-time doses, p<0.001.
‡Early interval of dose 3 from dose 1 occurred significantly more often than other early dosing intervals, p<0.002.
Six of the seven extra doses were prior to the appropriately timed triplet, and one of the seven was after the appropriately timed triplet.